425
Views
1
CrossRef citations to date
0
Altmetric
Review

Effect of biological DMARDs and JAK inhibitors in pain of chronic inflammatory arthritis

, , , , &
Pages 1311-1322 | Received 30 May 2022, Accepted 23 Sep 2022, Published online: 14 Oct 2022
 

ABSTRACT

Introduction

The advent of biological disease‐modifying anti‐rheumatic drugs (bDMARDs) and, more recently, of Janus kinase inhibitors (JAKi) has had a major impact on the long-term outcomes of chronic inflammatory arthritis (IA). However, the persistence of pain, even in patients with a complete pharmacological control of peripheral inflammation, represents an important clinical challenge in the treatment of IA.

Areas covered

In this review, we provide an overview of possible mechanisms underlying pain in IA and its assessment, as well as the effects of bDMARDs and JAKi on pain management.

Expert opinion

The overall data showed a good effect of bDMARDs and JAKi on pain, which is more pronounced for JAKi. However, it is challenging to distinguish the effect on the different types of pain (nociceptive, neuropathic, and nociplastic).

Article highlights

  • Pain in chronic inflammatory arthritis is a complex phenomenon derived from the interplay of multiple pain mechanisms

  • Biological disease‐modifying anti‐rheumatic drugs and Janus kinase inhibitors have a good efficacy and safety profile for treating patients with rheumatic inflammatory disease

  • These drugs are associated with the improvement of pain

  • However, a group of patients with persistent pain remains and should be the object of future research

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Author contributions

A Alciati, F Atzeni, M Di Carlo, C Siragusano, A Palumbo, IF Masala participated in the literature search and the summary of all articles. All of the authors drafted the manuscript, which was critically reviewed by F Atzeni and A Alciati. All of the authors read and approved the final manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 960.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.